DK584089A - Quinuclidiner, deres anvendelse som laegemiddel og fremgangsmaade til deres fremstilling - Google Patents

Quinuclidiner, deres anvendelse som laegemiddel og fremgangsmaade til deres fremstilling

Info

Publication number
DK584089A
DK584089A DK584089A DK584089A DK584089A DK 584089 A DK584089 A DK 584089A DK 584089 A DK584089 A DK 584089A DK 584089 A DK584089 A DK 584089A DK 584089 A DK584089 A DK 584089A
Authority
DK
Denmark
Prior art keywords
quinuclidines
medicine
procedure
preparation
Prior art date
Application number
DK584089A
Other languages
English (en)
Other versions
DK584089D0 (da
DK170167B1 (da
Inventor
Gerhard Walther
Karl-Heinz Weber
Werner Stransky
Franz Josef Kuhn
Enzio Mueller
Helmut Ensinger
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of DK584089D0 publication Critical patent/DK584089D0/da
Publication of DK584089A publication Critical patent/DK584089A/da
Application granted granted Critical
Publication of DK170167B1 publication Critical patent/DK170167B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK584089A 1988-11-22 1989-11-21 Quinuclidiner, deres anvendelse som lægemiddel og fremgangsmåde til deres fremstilling samt farmaceutisk præparat indeholdende en sådan forbindelse og fremgangsmåde til fremstilling af præparatet DK170167B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3839385A DE3839385A1 (de) 1988-11-22 1988-11-22 Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung
DE3839385 1988-11-22

Publications (3)

Publication Number Publication Date
DK584089D0 DK584089D0 (da) 1989-11-21
DK584089A true DK584089A (da) 1990-05-23
DK170167B1 DK170167B1 (da) 1995-06-06

Family

ID=6367625

Family Applications (1)

Application Number Title Priority Date Filing Date
DK584089A DK170167B1 (da) 1988-11-22 1989-11-21 Quinuclidiner, deres anvendelse som lægemiddel og fremgangsmåde til deres fremstilling samt farmaceutisk præparat indeholdende en sådan forbindelse og fremgangsmåde til fremstilling af præparatet

Country Status (18)

Country Link
US (2) US5451587A (da)
EP (1) EP0370415B1 (da)
JP (1) JPH0686449B2 (da)
KR (1) KR0165667B1 (da)
AU (1) AU628884B2 (da)
BG (1) BG61859B2 (da)
CA (1) CA2003422C (da)
DE (3) DE3839385A1 (da)
DK (1) DK170167B1 (da)
ES (1) ES2054988T3 (da)
FI (1) FI91637C (da)
HU (1) HU202527B (da)
IE (1) IE62328B1 (da)
IL (1) IL92377A (da)
NO (1) NO172801C (da)
NZ (1) NZ231445A (da)
PT (1) PT92368B (da)
ZA (1) ZA898858B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1307790C (en) * 1987-08-04 1992-09-22 Ian Anthony Cliffe Ethers
YU84791A (sh) * 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
EP0492904A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted benzene derivatives for use in the treatment of glaucoma
EP0492903A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
EP0492902A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyridine derivatives for use in the treatment of glaucoma
ZA92278B (en) * 1991-02-01 1992-10-28 Akzo Nv 3-quinuclidine derivatives
GB9122988D0 (en) * 1991-10-30 1991-12-18 Ici Plc Heterocyclic compounds
GB9127279D0 (en) * 1991-12-23 1992-02-19 Ici Plc Heterocyclic derivatives
US5612352A (en) * 1992-04-10 1997-03-18 Zeneca Limited Heterocyclic compounds
GB9211796D0 (en) * 1992-06-04 1992-07-15 Ici Plc Heterocyclic derivatives
GB9216721D0 (en) * 1992-08-06 1992-09-23 Ici Plc Therapeutic heterocyclic derivatives
GB9218334D0 (en) * 1992-08-28 1992-10-14 Ici Plc Heterocyclic compounds
DE4236331A1 (de) * 1992-10-28 1994-05-05 Boehringer Ingelheim Kg Synergistische Kombination
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5512574A (en) * 1994-12-21 1996-04-30 American Home Products Corporation Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
ES2147889T3 (es) 1996-01-19 2000-10-01 Lonza Ag Metodo para preparar 3-hidroxiquinuclidinol opticamente activo.
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
AU6896098A (en) * 1997-04-11 1998-11-11 Eli Lilly And Company Method for treating schizophrenia
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
DE10106971A1 (de) * 2001-02-15 2002-08-29 Boehringer Ingelheim Pharma Arzneimittelformulierung die einen muskarinischen Agonisten enthält
KR100448002B1 (ko) * 2002-02-01 2004-09-13 한국과학기술연구원 신규한 퀴누클리딘 화합물 및 그 제조방법
KR20030083289A (ko) * 2002-04-20 2003-10-30 한승호 다공질 화분
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US12653779B2 (en) 2015-06-18 2026-06-16 Lenz Therapeutics Operations, Inc. Compositions and methods for the treatment of presbyopia
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
JP2022511051A (ja) * 2018-12-05 2022-01-28 レンズ・セラピューティクス・インコーポレイテッド キヌクリジン環含有ムスカリン性アゴニストのプロドラッグ及びその組成物ならびに方法
WO2023091439A1 (en) 2021-11-17 2023-05-25 Lenz Therapeutics, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2014831A1 (en) * 1968-08-01 1970-04-24 Sogeras Quinuclidinyl and quinuclidinylalkyl ethers with cholino - lytic, antihistaminic and neurosedative activity
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT92368A (pt) 1990-05-31
NZ231445A (en) 1991-08-27
IE893712L (en) 1990-05-22
DE3839385A1 (de) 1990-05-23
DE58904567D1 (de) 1993-07-08
BG61859B2 (bg) 1998-07-31
EP0370415A1 (de) 1990-05-30
NO172801B (no) 1993-06-01
JPH02243688A (ja) 1990-09-27
DK584089D0 (da) 1989-11-21
AU628884B2 (en) 1992-09-24
NO172801C (no) 1993-09-08
HU202527B (en) 1991-03-28
CA2003422A1 (en) 1990-05-22
DK170167B1 (da) 1995-06-06
PT92368B (pt) 1995-07-18
NO894630D0 (no) 1989-11-21
FI91637C (fi) 1994-07-25
IE62328B1 (en) 1995-01-25
DE8817121U1 (de) 1993-02-04
NO894630L (no) 1990-05-23
ZA898858B (en) 1991-07-31
EP0370415B1 (de) 1993-06-02
ES2054988T3 (es) 1994-08-16
FI895531A0 (fi) 1989-11-21
US5451587A (en) 1995-09-19
CA2003422C (en) 1999-12-21
KR0165667B1 (ko) 1999-01-15
IL92377A0 (en) 1990-07-26
IL92377A (en) 1995-01-24
US5508405A (en) 1996-04-16
FI91637B (fi) 1994-04-15
KR900007837A (ko) 1990-06-02
JPH0686449B2 (ja) 1994-11-02
AU4540389A (en) 1990-05-31
HUT53102A (en) 1990-09-28
HU896032D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
DK584089D0 (da) Quinuclidiner, deres anvendelse som laegemiddel og fremgangsmaade til deres fremstilling
DK132789D0 (da) 9-halogen-(z)-prostaglandinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
NO881164L (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
DK660788A (da) 2,2-difluorcyklopropylethanderivater, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel
DK381985D0 (da) 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel
DK209188A (da) Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel
NO870666L (no) Substituerte thienoinidasolderivater, fremgangsmaate til deres fremstilling og farmasoeytiske tilberedninger inneholdende disse og deres anvendelse som magesyresekresjonshemmer
DK143284A (da) Thiazolinderivater, deres fremstilling og anvendelse som laegemiddel
DK373787D0 (da) Substituerede hydrazoner, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel
DK593883A (da) Substituerede phenylsulfonyloxybenzimidazolcarbaminater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK168786A (da) Hidtil ukendte dopaminderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
NO882112D0 (no) Substituerte vinylcefalosporiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel.
NO890096L (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
DK506183A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK627684A (da) 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel
DK403585A (da) Histargin-beslaegtede forbindelser, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
DK469389D0 (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK42888A (da) Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel
DK120789D0 (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
DK120889D0 (da) 3-(2,3,4,5,6-pentafluorphenoxy)-8-azabicyclooe3.2.1aaoctaner, en fremgangsmaade til deres fremstilling og deres anvendelse som medikamenter
NO822534L (no) Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
DK225189D0 (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK278290A (da) Substituerede 6h-pyridooe4,3-baacarbazoler og deres anvendelse som laegemidler
DK547289D0 (da) Benzoisothiazoler og fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired